摘要:
Provided is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, A is C 6-10 arylene, etc.; R 1a , R 1b and R 1c each independently is a hydrogen atom, a halogen atom, a C 1-4 alkyl group, a C 1-4 alkoxy group, etc.; R 2 is an optionally substituted C 6-10 aryl group, an optionally substituted 5- to 12-membered monocyclic or polycyclic heteroaryl group, an optionally substituted C 7-16 aralkyl group, etc.; m is 0, etc.; n is an integer of 0 to 2.)
摘要翻译:提供由式(1)表示的化合物或其药理学上可接受的盐。 (式中,A为C 6-10亚芳基等; R 1a,R 1b和R 1c各自独立地为氢原子,卤原子,C 1-4烷基,C 1-4烷氧基 R 2为任选取代的C 6-10芳基,任选取代的5至12元单环或多环杂芳基,任选取代的C 7-16芳烷基等; m为0等 。; n为0〜2的整数。)
摘要:
Disclosed is a novel process intermediate represented by the general formula (1) or (2): wherein X represents a halogen atom, a cyano group or the like; Y represents a halogen atom, a cyano group or the like; R1 represents a C1-C6 haloalkyl group or a C3-C8 halocycloalkyl group; R2 represents a methyl group, a halogen atom, a cyano group or the like; m represents an integer of 0 to 5; and n represents an integer of 0 to 4.
摘要:
Method for producing aromatic and heteroaromatic carboxylic acids, carboxylic acid esters and carboxylic acid amides through the reacting of aromatic or heteroaromatic halogenides R-X n , where n = a whole number from 1 to 6, R = a substituted or unsubstituted, aromatic or heteroaromatic radical and X = a chlorine, bromine or iodine atom; with carbon monoxide and water, ammonia, alcohols or amines in the presence of bases and nonvalent or bivalent palladium compounds and bidentate diphosphanes or complexes of nonvalent or bivalent palladium with bidentate diphosphanes, in which bidentate diphosphanes are used (R 1- )(R 2- )P-Y-P(-R 3 )(-R 4 ), with R 1 to R 4 =, unsubstituted aryl radicals or aryl radicals that are substituted with at least one radical having a positive resonance effect or a positive inductive effect, or unsubstituted or substituted cycloalkyl radicals; and Y = hydrocarbon groups with a total of 2 to 20 carbon atoms, wherein at least one of the carbon atoms carried only one or no hydrogen atom as a substituent; excepting the reaction of 4-bromo-3-difluoromethyl-1 -methylpyrazol with 2-(3,4,5-trifluoorphenyl)aniline and carbon monoxide to form N-[2-(3,4,5-Trifluorophenyl)phenyl]-3- difluoromethyl-1 -methylpyrazol-4-carboxylic acid amide.
摘要:
The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing two linked iodinated phenyl groups of the general formula R-N(CO-CH 3 ) — X— N(CO-CH 3 )- R and salts or optical active isomers thereof, wherein X denotes a divalent linking moiety with 5 to 10 bridge elements of carbon, oxygen, sulphur and nitrogen separating the acetylated nitrogen atoms, and which may be further substituted by hydroxyl groups, by C 1 to C 4 alkyl moieties optionally substituted by hydroxyl groups, by C 1 to C 4 alkoxy groups, by amino groups and by C 1 to C 4 alkylamino groups, and wherein 2 or 3 carbon bridge elements together with alkyl or alkoxy groups form a cyclopentane, cyclohexane, pentahydropyran or tetrahydrofuran entity which may be alkyl- or hydroxyalkyl- substituted and each R denotes a triiodinated phenyl residue further substituted by hydrophilic moieties. The invention also relates to the use of such diagnostic compositions as contrast agents in diagnostic imaging and in particular in X-ray imaging, and to contrast media containing such compounds.
摘要:
Disclosed are a method for improving the degradation of natural and/or synthetic polymers or a polymer article made from such polymer(s) by light and/or heat and/or humidity, comprising the incorporation of a compound of formula (I) into said natural and/or synthetic polymers: Formula (I); wherein m is 1 or 2, n is 1 to 100, X is selected from certain benzophenone-derived moieties and R, R1; R2 are each selected from list of certain residues; novel compounds of said formula (I) and polymeric articles of improved degradability in the presence of light and/or heat and/or humidity being made of a composition comprising: A) a natural and/or a synthetic polymer and B) a degradation accelerator being a compound of said formula (I).
摘要:
The present invention relates to novel compounds of the formula Ia: in any of its stereoisomeric forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity, and are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.
摘要:
There is provided a novel process intermediate represented by the general formula (1) or (2):
(where, X represents halogen atom, cyano group or the like, Y represents halogen atom, cyano group or the like, R 1 represents C 1 -C 6 haloalkyl group or C 3 -C 8 halocycloalkyl group, R 2 represents methyl group, halogen atom, cyano group or the like, m represents an integer of 1 to 5, and n represents an integer of 1 to 4).
摘要翻译:提供了由通式(1)或(2)表示的新颖的中间体:(其中,X表示卤素原子,氰基等,Y表示卤素原子,氰基等,R 1表示C 1 C 6卤代烷基或C 3 -C 8卤代环烷基,R 2表示甲基,卤素原子,氰基等,m表示1〜5的整数,n表示1〜4的整数。
摘要:
A compound of formula (I), or pharmaceutically acceptable salts thereof wherein X is selected from hydrogen, halo, -CN, -CON2, -CON(C1-6alkyl)H, -CON(C1-6alkyl)2 and heterocyclic groups; R1 is selected from C1-6alkyl and C3-6cycloalkyl; whereby Z is -OH, M is selected from C(O)- , -CH(ORa) , N(Ra) , and S(O)r-, wherein Ra is hydrogen or C1-6alkyl and r is 0, 1 or 2, R2 is selected from C1-6alkyl, C3-6cycloalkyl, heterocycloalkyl, aryl, alkylaryl, and heteroaryl, R2 is substituted with halo, -NO2, -CN, -OH, -CF3, -OCF3, -NH2, and/or -CONH2, when Y is -C1-6alkyl; or Z is -C1-6alkoxy, M is bond, R2 is selected from C1-6alkyl, C3-6cycloalkyl, heterocycloalkyl, aryl, alkylaryl, and heteroaryl, when Y is -C1-6alkoxy.
摘要:
The invention concerns products of formula (I) in which R1 represents -CONH - [A] - [B] -COR6, [A], [B]; R2, R3, R4, R5 and G are as defined in the description, and their salt additives with acids, bases and esters, the method for preparing them and the intermediates of said method, their application as medicines and the pharmaceutical compositions containing them.